Phosphorylated KDR can be located in the nucleus of neoplastic cells

被引:29
作者
Blazquez, C
Cook, N
Micklem, K
Harris, AL
Gatter, KC
Pezzella, F [1 ]
机构
[1] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Canc Res UK, Tumour Pathol Grp, Oxford OX3 9DU, England
[2] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Med Informat Unit, Oxford OX3 9DU, England
[3] John Radcliffe Hosp, Mol Oncol Lab, Canc Res UK, Oxford OX3 9DU, England
[4] Univ Complutense Madrid, Fac Biol, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain
关键词
KDR; human neoplasma; hypoxia; nucleus;
D O I
10.1038/sj.cr.7310012
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
KDR (kinase insert domain receptor) phosphorylation induces several effects which lead eventually to cell proliferation and survival. The precise mechanisms by which KDR, once it is activated, communicates with the nucleus are starting to be understood but have not yet been completely untavelled. Two in vitro studies on animal cell lines reported in the literature have demonstrated that, following stimulation with VEGF, KDR is actually translocated within the nucleus. Our aim was to investigate whether this translocation occurs in human cells both in vitro and in vivo. Using laser scanning confocal microscopy, a variable nuclear localization of phosphorylated and total KDR in cell lines and tumour samples was found. In human neoplastic cell lines, hypoxic Stimulation greatly increased the nuclear amount of total KDR but less so that of the phosphorylated form. Only after hypoxia and VEGF stimulation there was a comparably increased expression of phosphorylated and total KDR observed in the nuclei of these cells. We conclude that neoplastic cells show a variable expression of total and phosphorylated KDR in the nucleus. The precise functional meaning of nuclear location remains to be established.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 31 条
[1]   Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells [J].
Bartoli, M ;
Gu, XL ;
Tsai, NT ;
Venema, RC ;
Brooks, SE ;
Marrero, MB ;
Caldwell, RB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33189-33192
[2]   VEGF-VEGF receptor complexes as markers of tumor vascular endothelium [J].
Brekken, RA ;
Thorpe, PE .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :173-181
[3]  
BROWN LF, 1997, EXS, V79, P233, DOI DOI 10.1007/978-3-0348-9006-9_10
[4]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[5]   Presenilins and the intramembrane proteolysis of proteins: facts and fiction [J].
De Strooper, B ;
Annaert, W .
NATURE CELL BIOLOGY, 2001, 3 (10) :E221-E225
[6]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[7]   Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization [J].
Dougher, M ;
Terman, BI .
ONCOGENE, 1999, 18 (08) :1619-1627
[8]   VEGF: an update on biological and therapeutic aspects [J].
Farrara, N .
CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (06) :617-624
[9]   VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells [J].
Feng, YY ;
Venema, VJ ;
Venema, RC ;
Tsai, N ;
Caldwell, RB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (01) :192-197
[10]   Role of vascular endothelial growth factor in regulation of physiological angiogenesis [J].
Ferrara, N .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 280 (06) :C1358-C1366